LG-01 BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA

類似資料

• BI-21 BRAF MUTATION AND CDKN2A DELETIONS DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH GRADE GLIOMA
  著者:: Mistry, Matthew, 等
  出版事項: (2014)
• BRAF Mutation and CDKN2A Deletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
  著者:: Mistry, Matthew, 等
  出版事項: (2015)
• LG-03 RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY
  著者:: Krishnatry, Rahul, 等
  出版事項: (2015)
• LG-66 CLINICAL AND TREATMENT FACTORS DETERMINING LONG-TERM OUTCOMES FOR ADULT SURVIVORS OF CHILDHOOD LOW-GRADE GLIOMA: A POPULATION-BASED STUDY
  著者:: Zhukova, Nataliya, 等
  出版事項: (2016)
• LG-58 THERAPEUTIC IMPLICATIONS OF MOLECULAR BIOMARKERS IN INFANTS WITH PEDIATRIC LOW-GRADE GLIOMA
  著者:: Stucklin, Ana Guerreiro, 等
  出版事項: (2016)